孕前1小时血糖可早期提示IVF中PMOS/PCOS女性妊娠期糖尿病风险:多中心队列研究
该多中心回顾性队列纳入2571例在中国三家生殖医学中心接受首次IVF治疗且孕前行75g OGTT的PMOS/PCOS女性,主要结局为孕24-28周诊断的GDM。孕前空腹、1小时和2小时血糖均与GDM显著相关,其中1小时血糖关联更强且更一致;在糖尿病范围内仅1小时血糖≥11.6 mmol/l仍为显著指标。
要点
- 孕前1小时血糖与GDM关联强于空腹和2小时血糖。
- 糖尿病范围内仅1小时血糖≥11.6 mmol/l仍显著。
- 1小时血糖关联在正常体重和肥胖女性中显著,超重女性不显著。
核心结论
- 在行IVF治疗的PMOS/PCOS女性中,孕前1小时血糖与后续GDM的关联比空腹或2小时血糖更强且更一致。
主要发现
- 在糖尿病范围内,仅1小时血糖≥11.6 mmol/l仍为显著指标。
- 1小时血糖与GDM的关联在正常体重和肥胖女性中显著,在超重女性中不显著;各PMOS/PCOS表型间关联一致。
临床怎么用
- 孕前1小时血糖或可为识别正常体重和肥胖的PMOS/PCOS IVF女性中GDM高风险者提供额外价值,支持将其纳入孕前代谢评估考虑。
局限性
- 回顾性设计可能引入残余混杂并限制因果推断。
- 缺失数据需插补,亚组分析可能统计效能有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Is the preconception 1-h plasma glucose level during the oral glucose tolerance test (OGTT) more strongly associated with subsequent gestational diabetes mellitus than the fasting or 2-h glucose levels in women with PMOS/PCOS undergoing IVF treatment? SUMMARY ANSWER: Preconception 1-h plasma glucose showed a stronger and more consistent association with gestational diabetes mellitus than the fasting or 2-h glucose levels in women with PMOS/PCOS undergoing IVF treatment. WHAT IS KNOWN ALREADY: Women with PMOS/PCOS have an increased risk of gestational diabetes mellitus. International guidelines recommend a preconception OGTT in women with PMOS/PCOS without pre-existing diabetes because of the risk of hyperglycaemia and pregnancy complications. However, the comparative predictive value of different preconception OGTT time points, particularly 1-h glucose, remains unclear. STUDY DESIGN, SIZE, DURATION: This was a multi-centre retrospective cohort study including 2571 women with PMOS/PCOS who underwent their first IVF treatment at three reproductive medicine centres in China and had a preconception 75-g OGTT between March 2018 and December 2023. PARTICIPANTS/MATERIALS, SETTING, METHODS: Women with PMOS/PCOS who completed a preconception 75-g OGTT before initiation of the IVF treatment were included. The primary outcome was GDM diagnosed at 24-28 weeks of gestation. Generalized linear mixed-effects models were used to assess associations between OGTT glucose levels and GDM, adjusting for age, BMI, infertility duration, hormonal profiles, and treatment protocols. Stratified analyses by BMI and PMOS/PCOS phenotype were conducted, and multiple imputation was applied for missing data. MAIN RESULTS AND THE ROLE OF CHANCE: Preconception fasting (aOR 1.97 [1.49-2.61]), 1-h (aOR 1.23 [1.13-1.34]) and 2-h glucose (aOR 1.30 [1.17-1.45]) were all significantly associated with GDM (all P < 0.001). Within the diabetic range, only the 1-h glucose measurement of ≥11.6 mmol/l remained a significant indicator. The association of 1-h glucose with GDM was significant in normal-weight and obese women but not in overweight women. The associations were consistent across PMOS/PCOS phenotypes. LIMITATIONS, REASONS FOR CAUTION: The retrospective design may have introduced residual confounding and limits causal inference. Missing data required imputation, and subgroup analyses may have limited statistical power. WIDER IMPLICATIONS OF THE FINDINGS: These findings suggest that preconception 1-h glucose may provide additional value for identifying women who are a higher risk of GDM among normal-weight and obese women with PMOS/PCOS undergoing IVF treatment, and support its consideration in preconception metabolic assessments. FUNDING: This work was supported by the National Natural Science Foundation of China (82522038, 82471670 and 82401908), the Natural Science Foundation of Fujian Province (2025J011428), and the "Yongjiang Science and Technology Innovation 2035" Key Research and Development Program (2025Z151). DISCLOSURES: The authors declared no competing interests. TRIAL REGISTRATION NUMBER: N/A.
引用
- Wang G, Xie L, Chen Y, et al. Preconception 1-hour blood glucose as an early indicator of gestational diabetes mellitus risk in PMOS/PCOS women undergoing IVF treatment: a multi-centre cohort study. Hum Reprod. 2026. PMID: 42571879. doi:10.1093/humrep/deag119
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。